Twin Capital Management Inc. grew its stake in Davita Inc (NYSE:DVA) by 10.4% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 37,125 shares of the company’s stock after buying an additional 3,491 shares during the quarter. Twin Capital Management Inc.’s holdings in Davita were worth $2,578,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Vigilant Capital Management LLC boosted its stake in shares of Davita by 250.0% in the 2nd quarter. Vigilant Capital Management LLC now owns 2,100 shares of the company’s stock valued at $146,000 after buying an additional 1,500 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. purchased a new position in shares of Davita in the 2nd quarter valued at about $206,000. IBM Retirement Fund purchased a new position in shares of Davita in the 1st quarter valued at about $212,000. IFG Advisory LLC purchased a new position in shares of Davita in the 2nd quarter valued at about $213,000. Finally, Pendal Group Ltd purchased a new position in shares of Davita in the 1st quarter valued at about $242,000. Institutional investors and hedge funds own 87.80% of the company’s stock.
Several equities analysts have recently issued reports on the company. Zacks Investment Research upgraded Davita from a “sell” rating to a “hold” rating in a research note on Tuesday, August 7th. William Blair reiterated a “buy” rating on shares of Davita in a research note on Wednesday, June 6th. Four analysts have rated the stock with a hold rating, five have given a buy rating and two have given a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $82.13.
DVA stock opened at $67.83 on Friday. The company has a market cap of $11.20 billion, a P/E ratio of 20.43, a price-to-earnings-growth ratio of 1.00 and a beta of 1.10. Davita Inc has a fifty-two week low of $52.51 and a fifty-two week high of $80.71. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.90 and a quick ratio of 1.88.
Davita (NYSE:DVA) last posted its earnings results on Wednesday, August 1st. The company reported $1.05 earnings per share for the quarter, topping the consensus estimate of $0.97 by $0.08. The firm had revenue of $2.89 billion during the quarter, compared to analysts’ expectations of $2.88 billion. Davita had a return on equity of 14.49% and a net margin of 4.30%. The firm’s revenue was up 6.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.92 earnings per share. sell-side analysts anticipate that Davita Inc will post 4 earnings per share for the current fiscal year.
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Recommended Story: Fundamental Analysis
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.